Exploring the Synergy Between Government Tech Innovators and Fraud Detection Experts
Harnessing Open Data to Revolutionize Fraud Identification
A groundbreaking collaboration has emerged between Nick Shirley,...
SpaceX launched its IPO on the same day the U.S. sent astronauts to the moon for the first time in 54 years. And the timing is appropriate: This is likely the last time NASA will try to send people to deep space without major assistance from a company that emerged from the venture-backed tech scene.
Before the Orion spacecraft even launched on Wednesday, NASA’s Artemis II moon mission — the first in 50 years — had already weathered a storm of complex challenges, like hydrogen and helium leaks, a faulty heat shield, and technical issues with its safety system. Now in space, these four brave astronauts face their most formidable
The U.S. Food and Drug Administration has approved Eli Lilly 's GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight loss medications. Lilly said the once-daily pill, Foundayo, will start shipping from direct-to-consumer platform LillyDirect on Monday and will be available at
From Pizza Hut to Dunkin', Tom Brady is seemingly everywhere these days promoting food brands he once wouldn't have touched during his NFL playing days. The seven-time Super Bowl winning quarterback famously followed a strict health-focused diet and once referred to soda and sugary cereals as "poison for kids." But Brady says he's softened his
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a multi-month subscription program for its Wegovy obesity drug products that aims to ensure cash-paying patients see lower, "predictable" monthly prices. Eligible patients can choose between three-, six- or 12-month subscriptions for the Wegovy injection or the two